vs
BJs RESTAURANTS INC（BJRI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是BJs RESTAURANTS INC的1.8倍（$622.0M vs $355.4M），Royalty Pharma plc净利率更高（34.4% vs 3.6%，领先30.9%），Royalty Pharma plc同比增速更快（4.8% vs 3.2%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 2.6%）
BJ's Restaurants Inc.是美国休闲连锁餐饮企业，旗下门店遍布美国多个地区，主打招牌深盘披萨、精酿啤酒、手工鸡尾酒及各类美式家常餐食，服务家庭聚餐、朋友聚会等多元客群，主打轻松舒适的用餐氛围。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BJRI vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$355.4M
营收增速更快
RPRX
高出1.6%
3.2%
净利率更高
RPRX
高出30.9%
3.6%
两年增速更快
RPRX
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $355.4M | $622.0M |
| 净利润 | $12.6M | $214.2M |
| 毛利率 | 74.5% | — |
| 营业利润率 | 3.1% | 62.4% |
| 净利率 | 3.6% | 34.4% |
| 营收同比 | 3.2% | 4.8% |
| 净利润同比 | -24.2% | 2.9% |
| 每股收益（稀释后） | $0.58 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BJRIRPRX
| Q4 25 | $355.4M | $622.0M | ||
| Q3 25 | $365.6M | $609.3M | ||
| Q2 25 | $348.0M | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | $325.7M | $593.6M | ||
| Q3 24 | $349.9M | $564.7M | ||
| Q2 24 | $337.3M | $537.3M | ||
| Q1 24 | — | $568.0M |
净利润BJRIRPRX
| Q4 25 | $12.6M | $214.2M | ||
| Q3 25 | $22.2M | $288.2M | ||
| Q2 25 | $13.5M | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | $-2.9M | $208.2M | ||
| Q3 24 | $17.2M | $544.0M | ||
| Q2 24 | $7.7M | $102.0M | ||
| Q1 24 | — | $4.8M |
毛利率BJRIRPRX
| Q4 25 | 74.5% | — | ||
| Q3 25 | 75.2% | — | ||
| Q2 25 | 75.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 73.4% | — | ||
| Q3 24 | 74.3% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | — | — |
营业利润率BJRIRPRX
| Q4 25 | 3.1% | 62.4% | ||
| Q3 25 | 5.8% | 70.1% | ||
| Q2 25 | 4.3% | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | -0.8% | 60.9% | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 2.4% | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率BJRIRPRX
| Q4 25 | 3.6% | 34.4% | ||
| Q3 25 | 6.1% | 47.3% | ||
| Q2 25 | 3.9% | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | -0.9% | 35.1% | ||
| Q3 24 | 4.9% | 96.3% | ||
| Q2 24 | 2.3% | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）BJRIRPRX
| Q4 25 | $0.58 | $0.49 | ||
| Q3 25 | $0.97 | $0.67 | ||
| Q2 25 | $0.58 | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | $-0.13 | $0.46 | ||
| Q3 24 | $0.72 | $1.21 | ||
| Q2 24 | $0.32 | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.8M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $366.2M | $9.7B |
| 总资产 | $1.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BJRIRPRX
| Q4 25 | $23.8M | $618.7M | ||
| Q3 25 | $26.0M | $938.9M | ||
| Q2 25 | $19.0M | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $18.4M | $929.0M | ||
| Q3 24 | $16.2M | $950.1M | ||
| Q2 24 | $18.8M | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务BJRIRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | $60.5M | $8.9B | ||
| Q2 25 | $85.5M | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $66.5M | $7.6B | ||
| Q3 24 | $63.5M | $7.6B | ||
| Q2 24 | $58.0M | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益BJRIRPRX
| Q4 25 | $366.2M | $9.7B | ||
| Q3 25 | $386.6M | $9.6B | ||
| Q2 25 | $371.5M | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $376.2M | $10.3B | ||
| Q3 24 | $386.5M | $10.3B | ||
| Q2 24 | $375.4M | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产BJRIRPRX
| Q4 25 | $1.0B | $19.6B | ||
| Q3 25 | $1.0B | $19.3B | ||
| Q2 25 | $1.0B | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $1.0B | $18.2B | ||
| Q3 24 | $1.0B | $18.0B | ||
| Q2 24 | $1.0B | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比BJRIRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | 0.16× | 0.93× | ||
| Q2 25 | 0.23× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.18× | 0.74× | ||
| Q3 24 | 0.16× | 0.74× | ||
| Q2 24 | 0.15× | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BJRIRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $62.3M | $702.6M | ||
| Q2 25 | $4.6M | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | $27.3M | $742.5M | ||
| Q3 24 | $20.2M | $703.6M | ||
| Q2 24 | $22.3M | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流BJRIRPRX
| Q4 25 | — | — | ||
| Q3 25 | $41.9M | — | ||
| Q2 25 | $-12.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $735.0K | — | ||
| Q2 24 | $448.0K | — | ||
| Q1 24 | — | — |
自由现金流率BJRIRPRX
| Q4 25 | — | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | -3.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | — |
资本支出强度BJRIRPRX
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 6.5% | — | ||
| Q1 24 | — | — |
现金转化率BJRIRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 2.80× | 2.44× | ||
| Q2 25 | 0.34× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 1.18× | 1.29× | ||
| Q2 24 | 2.89× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BJRI
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
